Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Policy Revision for Local Coverage Determination Facet Joint Interventions for Pain Management - Effective July 17, 2025 Jul 17, 2025
Open Meeting Announcement - MolDX: Molecular Testing for Solid Organ Allograft Rejection - August 26, 2025 Jul 17, 2025
Open Meeting Announcement - MolDX: Biomarker Testing for Risk Stratification in DCIS - August 27, 2025 Jul 17, 2025
MolDX: Molecular Testing for Solid Organ Allograft Rejection - Published for Review and Comments Jul 17, 2025
MolDX: Biomarker Testing for Risk Stratification in DCIS - Published for Review and Comments Jul 17, 2025
Multi-Jurisdictional CAC Meeting Announcement - MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, Neoplasia - September 4, 2025, 1 - 3 p.m. CT Jul 17, 2025
Multi-Jurisdictional CAC Meeting Announcement - MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, Neoplasia: Agenda Jul 17, 2025
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973) - R9 - Effective July 1, 2025 Jul 10, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R11 - Effective July 1, 2025 Jul 10, 2025
MolDX: Molecular Testing for Solid Organ Allograft Rejection (L38629) - R1 - Effective July 10, 2025 Jul 10, 2025